ReutersThe company made its debut on the stock exchanges on Tuesday. It also launched its IPO this year.
The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Email sent to the company for a reaction in the matter has not elicited any response.
Thursday, 11 May, 2023- Front Page
- Pure Politics
- Companies
- Brands & Companies
- More
- NCLT OKs Go First Flight to Insolvency Protection
A bankruptcy court in New Delhi Wednesday approved the application of Go Airlines (India) to admit the carrier into the insolvency resolution process, allowing the first such voluntary bankruptcy protection involving a local airline. One of the biggest lessors may file an appeal against the order soon.
US Investor Slashes Ola Valuation by 35% to $4.8 BillionFunds managed by US investment firm Vanguard marked down the valuation of ride-hailing company Ola by 35% to $4.8 billion from $7.4 billion, according to regulatory filings with the US Securities and Exchange Commission.
Sebi Moots Higher Threshold for Investment in AIFsThe capital market regulator on Wednesday broached the idea of raising the minimum ticket size of investment in private equity (PE) and venture capital (VC) funds while favouring a regime that eventually paves the way for only deep-pocketed investors to put money in these funds.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Recommended Stories
- Reliance in fray as MG Motor looks to sell India ops: Reports
- Packaged foods give bite to FMCG sales volumes in January-March
- Frank talks with consumers key amid fake news: Chief executives of foods companies
- Indian office assets remain a big draw for global investors: Colliers Asia Pacific CEO
- OTTs may not bankroll films with a poor box office show
- Digital transactions on the rise, but banks 'branch out' to drive growth
- NARCL offers to buy Rs 1,100 crore loans of Parenteral Drugs
- Supreme Court upholds ₹278-crore award in Reliance Infra's Favour
- India to seek pharma IPR waiver for future pandemics
- Customs holds 800 containers of heavy melting scrap across key ports
